• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2004 Fiscal Year Final Research Report Summary

TOPOISOMERASE INHIBITORS ENHANCE THE CYTOCIDAL EFFECT OF AAV-HSVTK/GANCICLOVIR ON CANCER CELLS

Research Project

Project/Area Number 14571627
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Otorhinolaryngology
Research InstitutionUniversity of the Ryukyus

Principal Investigator

SHINHAMA Akihiko  University of the Ryukyus, Faculty of Medicine, Department of Otorhinolaryngology-Head and Neck Surgery, Instructor, 医学部, 助手 (60284973)

Co-Investigator(Kenkyū-buntansha) KOUCHI Ayako  University of the Ryukyus, Faculty of Medicine, Department of Otorhinolaryngology-Head and Neck Surgery, Instructor, 医学部, 助手 (30264500)
GANAHA Akira  University of the Ryukyus, Faculty of Medicine Hospital, Department of Otorhinolaryngology, Instructor, 医学部附属病院, 助手 (00347155)
Project Period (FY) 2002 – 2004
KeywordsAdeno-associated virus vector / Head and Neck Cancer / Chemotherapy / Suicide Gene / Combined Therapy
Research Abstract

Adeno-associated virus(AAV) is a nonpathogenic virus with a single-strand DNA genome. AAV vectors have several unique properties suited for gene therapy applications. However, an obstacle to their application is a low efficiency of transgene expression, mainly due to a limited second-strand synthesis. In the present study, we investigated whether topoisomerase inhibitors (etoposide and camptothecin) enhance the AAV vector-mediated transgene expression and the killing effect by AAVtk/GCV system. The enhancement of transgene expression was observed in a concentration-dependent manner on human laryngeal carcinoma cells (HEp-2 cells) and HeLa cells. Southern analysis confirmed that etoposide enhanced the double-strand synthesis of the AAV vector genome in HEp-2 cells and HeLa cells. The cells were efficiently killed by AAVtk/GCV system, as expected. More importantly, both etoposide and camptothecin augmented the cytocidal effect of the AAVtk/GCV system. Following the in vitro experiments, we evaluated the transgene expression and the antitumor activity of the AAV vectors in nude mice inoculated with HEp-2 subcutaneously. The LacZ expression was observed in the xenografted tumors and the AAVtk/GCV system suppressed the tumors growth compared with any other control such as AAVLacZ/GCV, AAVtk/PBS. These findings suggest that the combination of AAV-mediated suicide gene therapy and treatment with topoisomerase inhibitors may have synergistic therapeutic effects in the treatment of cancers.

  • Research Products

    (1 results)

All 2004

All Journal Article (1 results)

  • [Journal Article] Topoisomerase inhibitors enhance the cytocidal effect of AAV-HSVth/ganciclovir on head and neck cancer cells.2004

    • Author(s)
      Takeharu Kanazawa, Hiroaki Mizukami, Hiroshi Nishino, Takashi Okada, Yutaka Hanazono, Akihiro Kume, Ken Kitamura, Keiichi Ichimura, Keiya Oazawa
    • Journal Title

      International Journal of Oncology 25

      Pages: 729-735

    • Description
      「研究成果報告書概要(和文)」より

URL: 

Published: 2006-07-11  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi